cGxP.wire https://validator.w3.org/feed/docs/rss2.html TaiMed Receives TFDA Notice for Trogarzo Philips Launches Alturion AI Ultrasound System for High-Volume Care Vaccinex Showcases Pepinemab Biomarker Results MAIA Biotechnology Reports Positive Phase 2 THIO-101 Data in Third-Line NSCLC Opus Genetics Provides BEST1 Phase 1/2 Trial Timeline for OPGx-BEST1 Data INmune Bio Reports Positive Phase 2 XPro Data CervoMed Completes Phase 2 Enrollment of Neflamapimod in nfvPPA Denali Therapeutics Showcases BBB Innovation at AAIC 2026 Sera Prognostics Reports Positive PRIME Trial Results Freenome Reports Strong SimpleScreen CRC Study Results Apertura Gene Therapy Advances NPC1 Gene Therapy Research MetaVia Advances DA-1726 Phase 1 Obesity Trial Octapharma USA Expands FDA Approval for wilate® in Children Viz.ai Expands AI Platform Into Neurodegenerative Disease Avance Clinical Unveils Asia Growth Strategy at BIO Asia–Taiwan Leads Biolabs Secures Priority Review for Opamtistomig Rani Therapeutics Expands Obesity Pipeline With PegBio Teva Expands Global Biosimilar Portfolio With Polpharma Accord BioPharma’s ENNUMO Receives FDA Approval Porton Advanced Secures FDA DMF for UC-MSC Cell Bank WuXi Biologics MFG8 Secures FDA PLI for Autoimmune Therapy InxMed Publishes Landmark Ifebemtinib NSCLC Trial Results PreludeDx Expands DCIS Education Through New Collaboration MindMaze Supports Stroke Recovery Combination Therapy Study Ipsen Reports Positive Phase III Dysport Migraine Results Roche Receives CE Mark for Elecsys IGRA TB Test Johnson & Johnson Wins FDA Approval for Dual Energy Platform Arcutis FDA Accepts ZORYVE sNDA for Infant Dermatitis iHealthScreen Wins FDA 510(k) for iPredict-DR Software UroGen Announces FDA Clearance of IND for UGN-501 in Bladder Cancer Sino Biopharm Secures $2.1B TQC3721 AstraZeneca Agreement Immunome NDA for Varegacestat Accepted by FDA for DTs 60 Degrees Pharma Expands Tick-Borne Disease Pipeline Biocytogen Partners Whitehawk on BsADC Cancer Therapies Vera Therapeutics Wins FDA Approval for TRUTAKNA in IgAN Francis Medical Achieves California Vanquish Milestone Akston Reports Positive Canine Osteoarthritis Study Results Penumbra Enrolls First Patient in FORWARD Stroke Study Rhythm Publishes Phase 3 IMCIVREE Data in NEJM GeneCentric Launches ExpressCT Rewind to Unlock Gene Expression from Liquid Biopsy Data Genespire Reports Durable Preclinical Gene Therapy Results for Methylmalonic Acidemia Chemomab and Scipher Unite for AI-Powered Rheumatoid Arthritis Satellos Reports Positive Six-Month SAT-3247 Data OKYO Pharma Receives FDA Support for Phase 3 Trial Seres Therapeutics Reports Positive Early SER-155 Data Angelini Ventures Invests in Handspring Health Series B LTZ Therapeutics Receives FDA IND Clearance for LTZ-232 Nucleus Biologics Launches CRAIC Formulation Finder FibroBiologics Advances CYWC628 DFU Trial Manufacturing Nyra Medical Enrolls First Patient in ENHANCE EFS Trial